Biomarin Pharmaceutical Inc. - Registered Shares

+1.22 (+1.56%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)14.87B
Current PE377.80
Forward PE 116.76
2yr Forward PE 37.1
See more stats
Estimates Current Quarter
Revenue$524.63 Million
Adjusted EPS$0.04
See more estimates
10-Day MA$78.66
50-Day MA$80.17
200-Day MA$81.69
See more pivots

Biomarin Pharmaceutical Inc. - Registered Shares Stock, NASDAQ:BMRN

770 Lindaro Street, San Rafael, California 94901
United States of America
Phone: +1.415.506.6700
Number of Employees: 3045


BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.